Caution Urged With Paxlovid in Transplant Patients

(MedPage Today) -- Solid organ transplant recipients prescribed nirmatrelvir/ritonavir (Paxlovid) for COVID-19 should have their immunosuppressive drugs held and medication concentrations checked, and should undergo drug monitoring every 2 weeks...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news